Back to Search Start Over

MYOD1 as a prognostic indicator in rhabdomyosarcoma

Authors :
A S Gamis
Miriam R Conces
Lea F. Surrey
Nikolina Dioufa
Michael Arnold
Sahibu Sultan M Habeebu
Maria Tsokos
Selene C. Koo
Elizabeth Gonzalez
Frederic G. Barr
Terrie G Flatt
Atif A. Ahmed
Midhat S. Farooqi
Ashley K. Sherman
Source :
Pediatr Blood Cancer
Publication Year :
2021

Abstract

BACKGROUND/OBJECTIVES: Rhabdomyosarcoma (RMS) is characterized by the expression of the myogenic regulatory protein MYOD1. Histologic types include alveolar, embryonal (ERMS), and spindle cell sclerosing RMS (SRMS). SRMS harbors MYOD1 mutations in a subset of adult cases in association with poor prognosis. DESIGN/METHODS: To study the level of MYOD1 protein expression and its clinical significance, we have analyzed variable numbers of pediatric (

Details

ISSN :
15455017
Volume :
68
Issue :
9
Database :
OpenAIRE
Journal :
Pediatric bloodcancerREFERENCES
Accession number :
edsair.doi.dedup.....2740452d814de9edb3e742bdab93742a